Ketamine
Ketamine 是目前在国外临床研究中出现的一款新药或疗法，主要研究方向为Depression - Major Depressive Disorder、Treatment-resistant Depression (TRD)、rTMS、Ketamine。下面汇总了它当前在全球正在招募患者的研究，以及中国患者可以走的申请途径。
24 项
全球在招研究
9 项
已进入 III/IV 期
12 个
开展国家和地区
有
中国境内设点
药品与企业信息
研发企业
- Weill Medical College of Cornell University
- Neuronetics
- Min Su
- McGill University
- Loyola University
- Sohag University
- The Ketamine Research Foundation
- University of Utah
汇总自相关试验登记的主要申办方；研究机构申办时会显示相应机构名称。
生产企业
公开药品批准资料或正式说明书暂未提供明确的生产企业信息。
研发企业与生产企业可能不是同一家。研究阶段药品可能尚未公布生产企业；生产企业仅取自美国上市原研药说明书所列企业（不含仿制药），不作推测；仅在其他国家上市的药品暂无法显示。
主要开展国家和地区
美国、中国、加拿大、Egypt、意大利、西班牙、Oman、Colombia、Malaysia、Greece、Croatia、法国
正在招募患者的 Ketamine 研究
Retrospective Analyses of the Greenbrook Database Evaluating Mental Health Treatments
不适用招募中美国NCT06997549Subanesthetic Esketamine in Modified ECT for Severe Depression in Adolescents: Clinical and Mechanistic Study
早期 I 期招募中中国NCT07247968Music as an Adjunct to Ketamine Therapy for Chronic Pain
不适用招募中加拿大NCT06994559Ketamine as a Supplement to Local Anesthesia for Minor Procedures
IV 期招募中美国NCT06284473Dexmedetomidine Versus Dexmedetomidine and Ketamine (Ketodex) in Ear and Nose Surgeries
不适用招募中EgyptNCT06981494Clinical Trial Exploring the Outpatient Treatment of Phantom Limb Pain With Ketamine Administration in a Six Month Study With a Minimum Remission Period of 7 Days Between Treatment Session. 25-30 Subjects With an Ongoing History of Significant PLP.--FDA and IRB Approved.
II 期 / III 期招募中美国NCT07276542Ketamine Assisted Psychotherapy for Opioid Use Disorder
I 期 / II 期招募中美国NCT04892251Esketamine Nasal Spray in Real-World Settings in Treatment-Resistant Depression
不适用招募中意大利NCT07146503Prospective Multicentre Observational Registry of Peri-procedural Anaesthesia, Sedation and Related Medication Exposure in Patients With Brugada Syndrome
不适用招募中西班牙NCT07655102Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs
III 期招募中EgyptNCT04928300Premedication in Children: a Clinical Trial Comparing Oral Ketamine and Oral Clonidine With Respect to Sedation Level and Opioid Consumption in Pediatrics Undergoing Elective Lower Abdominal Day-case Surgery.
不适用招募中EgyptNCT07461376KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury
II 期招募中美国NCT07563296Nebulized Ketamine Plus Standard Care vs. Standard Care Alone in Moderate to Severe Asthma Exacerbations
II 期招募中OmanNCT07112456Prospective Feasibility, Analgesic Effectiveness, and Safety Study of a Visual Analog Scale-Guided Multimodal Pain Algorithm After Posterior Rib Remodeling With Osteosynthesis
不适用招募中ColombiaNCT07805928Dexmedetomidine-Midazolam vs. Ketamine-Midazolam on Emergence Delirium
IV 期招募中EgyptNCT07427446Evaluation of Ketamine as Sedative Agent in Endoscopic Retrograde Cholangiopancreatography (ERCP)
IV 期招募中MalaysiaNCT04490031The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
II 期招募中美国NCT05786066Coaching as an Adjunct to Ketamine Therapy for Treatment-Resistant Depression
不适用招募中美国NCT07563868Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair
IV 期招募中GreeceNCT04894864Metabolic Profiling of Esketamine Treatment in Depressive Disorder
不适用招募中CroatiaNCT07002684Nebulized Ketamine to Nebulized Fentanyl for Treating Acute Painful Conditions in the ED
IV 期招募中美国NCT06364540Effect of Dexmedetomidine and Esketamine on Catheter-related Bladder Discomfort
IV 期招募中中国NCT06399185Ketamine Treatment Plans for Chronic Conditions
不适用招募中美国NCT06038409Pain Reduction for Limb Injuries in Pediatric Emergency Departments: Intranasal Fentanyl or Intranasal Ketamine vs Oral Morphine
III 期招募中法国NCT06464146
中国患者怎么争取用上这款药
这款药已经有研究在中国境内设点，可以先带完整病历去对应医院咨询入组；同时也可以并行了解下面几条途径，多一条备选。
查看完整申请指南同类方向的其他在研新药
本页信息整理自 ClinicalTrials.gov 公开登记数据，仅供参考，不构成医疗建议；是否适合使用该药物，请以专业医生和研究团队的意见为准。